Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Adgero
3157
Adgero
Technology
Biotechnology
Adgero Biopharmaceuticals is leveraging its late stage photodynamic therapy (PDT) platform for the treatment of serious oncology indications.
Suggest edits
Founded
2012
Raised
$2M
Follow us
Companies in the same industry
Wyss Institute
Biotix
Uptake Medical
B-Bridge International
Gemmus Pharma
Glide Pharma
SAGE Therapeutics
Molcure
Receptos, Inc.
Topokine Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$2,000,000
Venture capital - 2017
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Team Size
2
Employees
I work here
Location
United States
Headquarters
Explore United States
$2,000,000
Venture capital
Marketwire
Adgero Biopharmaceuticals Holdings Inc. Announces $2.0 Million Investment from Strategic Asian Investor
$9,700,000
Venture capital
Marketwire
Adgero Biopharmaceuticals Completes $9.7 Million Equity Financing
Health
Ecosummit
Adgero Market
Self driving cars
Energy
